Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression

Wentao Li, Lin Liang, Siyi Liu, Jingqiong Tang, Shuangyan Ou, Zhijun Yuan, Yanhong Zhou, Xia Yuan · 2025

Read Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression by Wentao Li, Lin Liang, Siyi Liu, Jingqiong Tang, Shuangyan Ou, Zhijun Yuan, Yanhong Zhou, Xia Yuan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12741050.txt.

Description

Eight authors led by Wentao Li find a growth factor that drives bowel cancer on two fronts at once. Bowel cancer is a common killer whose growth rules are still partly dark. The factor, called INHBA, sat high in tumour tissue and tracked with poor outcomes for patients. In dish and mouse tests, high levels sped cancer cell growth, spread, and tissue entry. Cutting the factor slowed all three.

One front is immune: the factor flips guard cells near the tumour to a state that shelters it. The flip runs through a carrier protein the factor also shields from cell trash runs. The other front is cell death: the factor blocks a rust-like death path inside cancer cell power units. Both fronts make INHBA a drug target of note for bowel cancer.

Catalog record

CREATORWentao Li, Lin Liang, Siyi Liu, Jingqiong Tang, Shuangyan Ou, Zhijun Yuan, Yanhong Zhou, Xia Yuan
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE92 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12741050

Browse the full library · About the Tower of Babel